Article
Classification of tumor microenvironment immune types based on immune response-associated gene expression
2 Nov 2018
Abstract excerpt
In 2014, the Shizuoka Cancer Center launched project High‑tech Omics‑based Patient Evaluation (HOPE), which features whole exome sequencing (WES) and gene expression profiling (GEP) of fresh surgical specimens from cancer patients. With the development of clinical trials of programmed death‑1 (PD‑1)/PD‑ligand 1 (PD‑L1) blockade, PD‑L1 expression and a high tumor mutation burden become possible biomarkers that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.